Category Archives: Ask the CEO

No Comments on Ask the CEO – 4

The most frequently asked question in 2018: InflammAging

Dr. Wolfgang Brysch

Dr. Wolfgang Brysch

For this blog entry, we’ve been thinking: Is there a question that has been asked most frequently this year? And what does the answer say about our work at MetrioPharm?

The most frequently asked question clearly was: “Is MetrioPharm working on InflammAging?”

The so-call...

Read more

No Comments on Ask the CEO – 3

What kind of company is MetrioPharm?

Dr. Wolfgang Brysch

Dr. Wolfgang Brysch

We have spent this summer on the road. While the scientific team oversaw the progress of our Phase II clinical trial, our Business Development and Investor Relations staff introduced MetrioPharm AG to many different people: potential development partners, medical scientists, financial analysts, healthcare experts and investors.

Read more

No Comments on Ask the CEO – 2

Does MetrioPharm have competition?

Dr. Wolfgang Brysch

Dr. Wolfgang Brysch

When I get this question – which happens a lot – I usually answer: ‘Yes, MetrioPharm has competition. And then again, no, MetrioPharm has no competition.’

On the one hand, there are drugs for chronic inflammatory diseases already approved today, and our MP1032 will be competing with them...

Read more

No Comments on Ask the CEO – 1

10 years of MetrioPharm – which one was the most difficult?

Dr. Wolfgang Brysch

Dr. Wolfgang Brysch

Actually, it’s a routine question and I could have expected it. I was asked at our anniversary celebration last fall: “10 years of MetrioPharm – which one was the most difficult?” I had to think about that question for a moment. The year 2007 is not far in the past, still the difficulties of that time feel oddly distant now.

In 2008, right after the founding of the company, we were in...

Read more